Testing effectiveness (Phase 2)Active Not RecruitingNCT03920007
What this trial is testing
Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
Who this might be right for
Leber Congenital AmaurosisLCALCA1
Atsena Therapeutics Inc. 15